Cogprints

Optimal Agonist/Antagonist Combinations Maintain Receptor Response by Preventing Rapid beta1-Adrenergic Receptor Desensitization

Lanzara, Richard (2005) Optimal Agonist/Antagonist Combinations Maintain Receptor Response by Preventing Rapid beta1-Adrenergic Receptor Desensitization. [Journal (Paginated)]

Full text available as:

[img]
Preview
PDF
718Kb

Abstract

Desensitization is a serious side effect of many drugs. It is also a fundamental problem for modeling drug-receptor interactions. This study was designed to test a receptor model and a method to optimize agonist/antagonist combinations calculated to prevent receptor desensitization, which has relevance for many important drugs, including the b1-adrenergic agonist drugs. Because desensitization is a serious side effect, the beta1-adrenergic agonist drugs are no longer the logical treatment for heart failure and have been replaced by antagonist drugs represented by metoprolol (Lopressor). Although the scientific rationale for this remains unclear and because the agonist and antagonist drugs may be administered together in some medical circumstances, it is important to understand the early interactions of beta-agonist drugs with the beta-antagonist drugs at the level of the initial receptor response. Isoproterenol (Iso) or dobutamine (Dob) were given as intravenous solutions to rats with or without the beta1-antagonist, metoprolol (Met), which was given either as a fixed amount or as part of an agonist/antagonist combination. The Iso and Dob solutions alone demonstrated rapid desensitizaton, whereas the optimal Iso/Met and Dob/Met agonist/antagonist combinations significantly prevented desensitization while maintaining near maximal responses in all of the animals tested. The theory behind the model predicted these responses and fit the experimental data with reasonable biophysical parameters. This study supports the concept that the earliest events of receptor desensitization can be modeled and controlled at the level of the initial receptor response and also suggests that the beneficial effects of metoprolol for heart failure may result from its action on the earliest events of receptor activation.

Item Type:Journal (Paginated)
Additional Information:A newly derived receptor model that explains the action of agonists with antagonists in a specified ratio to prevent receptor desensitization.
Keywords:receptor model, beta-1-adrenergic receptor, desensitization, down-regulation, agonist/antagonist combinations, receptor theory, pharmacological theory
Subjects:Neuroscience > Neuropharmacology
ID Code:4093
Deposited By:Lanzara, Dr. Richard G.
Deposited On:13 Apr 2005
Last Modified:11 Mar 2011 08:55

References in Article

Select the SEEK icon to attempt to find the referenced article. If it does not appear to be in cogprints you will be forwarded to the paracite service. Poorly formated references will probably not work.

References

1. Bianchi, M.T., K.F. Haas and R.L. MacDonald, 2001. Structural Determinants of Fast Desensitization and Desensitization–Deactivation Coupling in GABAA Receptors. J. Neurosci., 21: 1127–1136.

2. Sullivan Hanley, N.R. and J.G. Hensler, 2002. Mechanisms of Ligand-Induced Desensitization of the 5-Hydroxytryptamine2A Receptor. J. Pharmacol. Exp. Ther., 300: 468–477.

3. Partin, K.M., 2001. Domain Interactions Regulating AMPA Receptor Desensitization. J. Neurosci., 21: 1939–1948.

4. He, M., T. Koshimizu, M. Tomic´ and S.S. Stojilkovic, 2002. Purinergic P2X2 Receptor Desensitization Depends on Coupling between Ectodomain and C-Terminal Domain. Mol. Pharmacol., 62: 1187–1197.

5. January, B., A. Seibold, B. Whaley, R.W. Hipkin, D. Lin, A. Schonbrunn, R. Barber and R.B. Clark, 1997. b2-Adrenergic Receptor Desensitization, Internalization, and Phosphorylation in Response to Full and Partial Agonists. J. Biol. Chem., 272: 23871–23879.

6. Bender, K., M. Wellner-Kienitz, A. Inanobe, T. Meyer, Y. Kurachi and L. Pott, 2001. Overexpression of Monomeric and Multimeric GIRK4 Subunits in Rat Atrial Myocytes Removes Fast Desensitization and Reduces Inward Rectification of Muscarinic K1 Current (IK(ACh)) Evidence for Functional Homomeric GIRK4 Channels. J. Biol. Chem., 276: 28873-28880.

7. Blanchet, C. and C. Lüscher, 2002. Desensitization of m-opioid receptor-evoked potassium currents: Initiation at the receptor, expression at the effector. Proc. Natl. Acad. Sci. USA, 99: 4674–4679.

8. Bünemann, M., K.B. Lee, R. Pals-Rylaarsdam, A.G. Roseberry and M.M. Hosey, 1999. Desensitization of G-Protein-Coupled Receptors in the Cardiovascular System. Annu. Rev. Physiol., 61: 169–92.

9. Marchant, J.S. and C.W. Taylor, 1998. Rapid Activation and Partial Inactivation of Inositol Trisphophate Receptors by Inositol Trisphosphate. Biochemistry, 37: 11524-11533.

10. Jones, M.V. and G.L. Westbrook, 1996. The impact of receptor desensitization on fast synaptic transmission. Trends in Neurosciences, 19: 96-112.

11. Sakmann, B., 1992. Elementary Steps in Synaptic Transmission Revealed by Currents through Single Ion Channels. Neuron, 8: 613-629.

12. Pao, C.S. and J.L. Benovic, 2002. Phosphorylation-independent desensitization of G protein-coupled receptors? Science's STKE 2002, http://www.stke.org/cgi/content/full/sigtrans;2002/153/pe42.

13. Post, S.R., H.K. Hammond and P.A. Insel, 1999. b-Adrenergic Receptors and Receptor Signaling in Heart Failure. Annu. Rev. Pharmacol. Toxicol., 39: 343–60.

14. Brouri, F., L. Findji, O. Mediani, N. Mougenot, N. Hanoun, G. Le Naour, M. Hamon and P. Lechat, 2002. Toxic cardiac effects of catecholamines: role of beta-adrenoceptor downregulation. Eur. J. Pharmacol., 456: 69-75.

15. McMartin, L. and R.J. Summers, 1999. Functional analysis of desensitization of the beta-adrenoceptor signalling pathway in rat cardiac tissues following chronic isoprenaline infusion. Br. J. Pharmacol., 127: 1012-20.

16. Hayes, J.S., N. Bowling and G.D. Pollock, 1985. Effects of beta adrenoceptor down-regulation on the cardiovascular responses to the stereoisomers of dobutamine. J. Pharmacol. Exp. Ther., 235: 58-65.

17. Lanzara, R., 1997. A Method for determining drug compositions to prevent desensitization of cellular receptors. U. S. Pat., 5,597,699.

18. Rockman, H.A., W.J. Koch and R.J. Lefkowitz, 2002. Seven-transmembrane-spanning receptors and heart function. Nature, 415: 206-212.

19. Swedberg, K., A. Hjalmarson, F. Waagstein and I. Wallentin, 1979. Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade. Lancet., 1: 1374-6.

20. Bond R.A., P. Leff, T.D. Jonhson, C.A. Milano, H.A. Rockman, T.R. McMinn, S. Apparsundaram, M.F. Hyek, T.P. Kenakin, L.F. Allen, R.J. Lefkowitz, 1995. Physiological Effects of Inverse Agonists in Transgenic Mice with Myocardial Overexpression of the Beta-2-Adrenoceptor. Nature, 374: 272-6.

Metadata

Repository Staff Only: item control page